Literature DB >> 3588650

WEB 2086. A potent PAF antagonist exerts protective effect toward PAF-induced gastric damage.

A Brambilla, A Ghiorzi, A Giachetti.   

Abstract

Single intravenous administration of platelet activating factor (PAF; 4 micrograms/kg) induced reproducible gastric damage in the conscious rat which was prevented by WEB 2086, a potent and specific PAF-antagonist. Intravenous and oral ED50s in protecting rats from gastric damage were 61 and 633 micrograms/kg, respectively. Because of the reported association between septic shock and gastrointestinal ulceration, the therapeutic potential of PAF-antagonists might be broader than previously thought.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3588650     DOI: 10.1016/0031-6989(87)90004-x

Source DB:  PubMed          Journal:  Pharmacol Res Commun        ISSN: 0031-6989


  2 in total

1.  The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves.

Authors:  M B Bastos da Silva; P Gustin; F Herion; R Raskinet; J L David; T Gougnard; G Plomteux; D Desmecht; P Lekeux
Journal:  Vet Res Commun       Date:  1997-10       Impact factor: 2.459

2.  Inhibitory effect of oral WEB 2086, a novel selective PAF-acether antagonist, on ex vivo platelet aggregation.

Authors:  W S Adamus; H Heuer; C J Meade; G Frey; H M Brecht
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.